RegenXBio (RB0) Ratios
RegenXBio Ratios
DE:RB0's free cash flow for Q2 2026 was $-63.00M. For the 2026 fiscal year, DE:RB0's free cash flow was decreased by $-760.00K and operating cash flow was $-62.24M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.38 | 2.69 | 2.57 | 3.19 | 3.98 |
| Quick Ratio | 2.38 | 2.69 | 2.57 | 3.19 | 3.98 |
| Cash Ratio | 0.29 | 0.56 | 0.26 | 0.74 | 2.65 |
| Solvency Ratio | -0.51 | -1.02 | -0.94 | -0.84 | 0.39 |
| Operating Cash Flow Ratio | -1.05 | -1.68 | -1.68 | -1.59 | 1.68 |
| Short-Term Operating Cash Flow Coverage | -2.59 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -69.02M | $ 71.66M | $ 72.74M | $ 98.90M | $ 169.22M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.58 | 0.18 | 0.16 | 0.11 | 0.08 |
| Debt-to-Equity Ratio | 2.54 | 0.32 | 0.29 | 0.18 | 0.11 |
| Debt-to-Capital Ratio | 0.72 | 0.24 | 0.22 | 0.16 | 0.10 |
| Long-Term Debt-to-Capital Ratio | 0.59 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 4.41 | 1.79 | 1.84 | 1.61 | 1.46 |
| Debt Service Coverage Ratio | -1.43 | -15.66 | -34.87 | -10.50 | 5.94 |
| Interest Coverage Ratio | -3.58 | -18.43 | -39.07 | -11.30 | 6.09 |
| Debt to Market Cap | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 5.92 | 1.91 | 2.20 | 2.74 | 2.66 |
| Net Debt to EBITDA | -1.70 | -0.12 | -0.23 | 0.01 | -1.52 |
| Profitability Margins | |||||
| Gross Profit Margin | 88.09% | 59.72% | 58.76% | 51.61% | 88.98% |
| EBIT Margin | -87.34% | -257.35% | -284.55% | -228.12% | 34.01% |
| EBITDA Margin | -78.18% | -237.89% | -265.36% | -216.67% | 36.05% |
| Operating Profit Margin | -94.58% | -280.03% | -297.12% | -233.20% | 34.01% |
| Pretax Profit Margin | -113.75% | -272.54% | -292.15% | -248.75% | 30.03% |
| Net Profit Margin | -113.75% | -272.54% | -291.99% | -248.68% | 27.18% |
| Continuous Operations Profit Margin | -113.75% | -272.54% | -291.99% | -248.68% | 27.18% |
| Net Income Per EBT | 100.00% | 100.00% | 99.94% | 99.97% | 90.51% |
| EBT Per EBIT | 120.27% | 97.32% | 98.33% | 106.67% | 88.29% |
| Return on Assets (ROA) | -42.80% | -48.74% | -45.91% | -33.64% | 11.48% |
| Return on Equity (ROE) | -188.72% | -87.46% | -84.52% | -54.31% | 16.73% |
| Return on Capital Employed (ROCE) | -48.13% | -64.32% | -60.43% | -37.40% | 16.27% |
| Return on Invested Capital (ROIC) | -42.11% | -62.95% | -59.45% | -37.07% | 14.70% |
| Return on Tangible Assets | -42.80% | -48.74% | -45.91% | -33.64% | 11.48% |
| Earnings Yield | -26.11% | -59.34% | -33.57% | -28.64% | 9.21% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.22 | 3.86 | 3.43 | 3.72 | 14.50 |
| Payables Turnover | 0.95 | 1.47 | 1.63 | 2.00 | 4.55 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 1.12 | 0.49 | 0.47 | 0.55 | 2.44 |
| Asset Turnover | 0.38 | 0.18 | 0.16 | 0.14 | 0.42 |
| Working Capital Turnover Ratio | 1.01 | 0.44 | 0.37 | 0.33 | 1.12 |
| Cash Conversion Cycle | -325.42 | -153.43 | -116.95 | -84.02 | -55.01 |
| Days of Sales Outstanding | 58.64 | 94.47 | 106.54 | 98.09 | 25.17 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 384.06 | 247.90 | 223.49 | 182.10 | 80.19 |
| Operating Cycle | 58.64 | 94.47 | 106.54 | 98.09 | 25.17 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -2.40 | -3.50 | -4.99 | -4.81 | 5.16 |
| Free Cash Flow Per Share | -2.45 | -3.55 | -5.22 | -5.52 | 3.17 |
| Dividend Paid and CapEx Coverage Ratio | -51.35 | -71.07 | -21.93 | -6.75 | 2.60 |
| Capital Expenditure Coverage Ratio | -51.35 | -71.07 | -21.93 | -6.75 | 2.60 |
| Operating Cash Flow Coverage Ratio | -0.48 | -2.11 | -2.45 | -2.19 | 2.53 |
| Operating Cash Flow to Sales Ratio | -0.73 | -2.08 | -2.42 | -1.84 | 0.47 |
| Free Cash Flow Yield | -17.02% | -45.87% | -29.09% | -24.34% | 9.71% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.83 | -1.68 | -2.98 | -3.49 | 10.86 |
| Price-to-Sales (P/S) Ratio | 4.36 | 4.59 | 8.70 | 8.68 | 2.95 |
| Price-to-Book (P/B) Ratio | 7.23 | 1.47 | 2.52 | 1.90 | 1.82 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.88 | -2.18 | -3.44 | -4.11 | 10.30 |
| Price-to-Operating Cash Flow Ratio | -5.99 | -2.21 | -3.59 | -4.72 | 6.34 |
| Price-to-Earnings Growth (PEG) Ratio | 0.21 | 0.07 | 0.40 | 0.01 | -0.05 |
| Enterprise Value Multiple | -7.27 | -2.05 | -3.51 | -4.00 | 6.66 |
| Enterprise Value | 968.70M | 407.21M | 839.79M | 976.53M | 1.13B |
| EV to EBITDA | -7.27 | -2.05 | -3.51 | -4.00 | 6.66 |
| EV to Sales | 5.68 | 4.89 | 9.31 | 8.66 | 2.40 |
| EV to Free Cash Flow | -7.67 | -2.32 | -3.68 | -4.10 | 8.38 |
| EV to Operating Cash Flow | -7.81 | -2.35 | -3.85 | -4.71 | 5.16 |
| Tangible Book Value Per Share | 1.99 | 5.24 | 7.13 | 11.96 | 18.01 |
| Shareholders’ Equity Per Share | 1.99 | 5.24 | 7.13 | 11.96 | 18.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 |
| Revenue Per Share | 3.30 | 1.68 | 2.06 | 2.61 | 11.08 |
| Net Income Per Share | -3.76 | -4.59 | -6.02 | -6.50 | 3.01 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 0.91 |
| Interest Burden | 1.30 | 1.06 | 1.03 | 1.09 | 0.88 |
| Research & Development to Revenue | 1.34 | 2.50 | 2.57 | 2.15 | 0.39 |
| SG&A to Revenue | 0.49 | 0.92 | 0.98 | 0.76 | 0.17 |
| Stock-Based Compensation to Revenue | 0.20 | 0.46 | 0.45 | 0.36 | 0.08 |
| Income Quality | 0.64 | 0.76 | 0.83 | 0.74 | 1.71 |
Currency in USD